Table 3 CDC, USPSTF, and WHO recommendations for cervical cancer and HPV screening in women depending on age and HIV co-morbidity
From: Human papilloma virus (HPV) mediated cancers: an insightful update
Female populations | WHO | CDC and USPSTF |
|---|---|---|
 < 21 | Not advised | Not advised |
21–30 | Not advised | Pap testing every three years |
30–65 | HPV DNA testing every 5–10 years; complete after 2 negative tests | Pap test every 3 years, Pap test with HPV co-testing every 5 years,or HPV testing every 5 years |
Having HIV | HPV DNA test starting at age 25 every 3–5 years | Pap test or Pap test with co-testing starting at age 21 yearly for three years then every three years for life |